SAN FRANCISCO, June 14, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock […]
Category Archives: Pr Newswire
Pr Newswire
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
15
Jun
Jun
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual European Hematology Association (EHA) 2024 Hybrid Congress. Galapagos’ product candidate GLPG5101 is […]
Pr Newswire
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
15
Jun
Jun
The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the International Association for the Study of Pain, and features original research on the nature, mechanisms and treatment of pain. This Phase 3 study met primary and […]
Abu Dhabi’s new AgriFood Growth & Water Abundance cluster taps into a USD 21.08 trillion industry The cluster is projected to attract USD 34.8 billion in investments, create more than 60,000 new jobs, and contribute USD 24.5 billion Abu Dhabi’s economy by 2045 ABU DHABI, UAE, June 15, 2024 /PRNewswire/ — Abu Dhabi is paving […]
SHENZHEN, China, June 15, 2024 /PRNewswire/ — The UEFA European Football Championship 2024 (UEFA EURO 2024™) opened on June 14, 2024, at the Munich Football Arena in Germany, amidst the anticipation of fans worldwide. As one of the most watched football tournaments globally, it brings together top teams from across Europe and attracts millions of football lover […]
TORONTO, June 15, 2024 /PRNewswire/ — Visionary Holdings Inc. (the “Company”) (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the Company’s CEO Mr. Zhong Chen‘ letter to the public. Due to the impact of […]
OKLAHOMA CITY, June 15, 2024 /PRNewswire/ — The Oklahoma Route 66 Centennial Commission proudly unveiled the official logo for the Oklahoma Route 66 Centennial celebrations during a kickoff event on June 13 at the Oklahoma State Capitol. This inaugural event marks the commencement of a series of celebrations leading up to the iconic Route 66’s 100th […]
NEW YORK, June 15, 2024 /PRNewswire/ — EaseUS Todo Backup, a leading provider of data backup and recovery solutions, released its latest version on May 29, 2024. This new version mainly provides enhanced support for APP Backup. Compared with the previous permission to back up only specific game archives(GTA V, Hogwart Legacy, The Sim 4, […]
Pr Newswire
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
14
Jun
Jun
A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients’ blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment […]
Pr Newswire
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
14
Jun
Jun
REDWOOD CITY, Calif., June 14, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today is presenting preclinical data […]